Abyssinia Biologics

Abyssinia Biologics

Pre-clinical
San Diego, United StatesFounded 2021aby-bio.com

Soluble oligomers of amyloid-beta (Aβ) are the most neurotoxic forms of Aβ. Unlike plaques, these soluble oligomers can disrupt synaptic function, impair neuronal communication, and lead to cognitive deficits even at low concentrations. They are thought to play a central role in the early stages of Alzheimer’s, contributing to synaptic loss and neurodegeneration as well as driving downstream pathologies like tau dysregulation.By potently and selectively targeting soluble oligomers and avoidin...

Founded
2021
Focus
AntibodiesBiologicsDiagnostics

About

Soluble oligomers of amyloid-beta (Aβ) are the most neurotoxic forms of Aβ. Unlike plaques, these soluble oligomers can disrupt synaptic function, impair neuronal communication, and lead to cognitive deficits even at low concentrations. They are thought to play a central role in the early stages of Alzheimer’s, contributing to synaptic loss and neurodegeneration as well as driving downstream pathologies like tau dysregulation.By potently and selectively targeting soluble oligomers and avoidin...

Company Info

TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile